GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Diasorin SpA (CHIX:DIAm) » Definitions » 3-Year FCF Growth Rate

Diasorin SpA (CHIX:DIAM) 3-Year FCF Growth Rate : -4.50% (As of Mar. 2025)


View and export this data going back to 2010. Start your Free Trial

What is Diasorin SpA 3-Year FCF Growth Rate?

Diasorin SpA's Free Cash Flow per Share for the three months ended in Mar. 2025 was €1.32.

During the past 12 months, Diasorin SpA's average Free Cash Flow per Share Growth Rate was 1.70% per year. During the past 3 years, the average Free Cash Flow per Share Growth Rate was -4.50% per year. During the past 5 years, the average Free Cash Flow per Share Growth Rate was 2.60% per year. During the past 10 years, the average Free Cash Flow per Share Growth Rate was 10.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Free Cash Flow per Share growth rate.

During the past 13 years, the highest 3-Year average Free Cash Flow per Share Growth Rate of Diasorin SpA was 69.40% per year. The lowest was -5.20% per year. And the median was 13.55% per year.


Competitive Comparison of Diasorin SpA's 3-Year FCF Growth Rate

For the Diagnostics & Research subindustry, Diasorin SpA's 3-Year FCF Growth Rate, along with its competitors' market caps and 3-Year FCF Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Diasorin SpA's 3-Year FCF Growth Rate Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Diasorin SpA's 3-Year FCF Growth Rate distribution charts can be found below:

* The bar in red indicates where Diasorin SpA's 3-Year FCF Growth Rate falls into.


;
;

Diasorin SpA 3-Year FCF Growth Rate Calculation

This is the 3-year average growth rate of Free Cash Flow per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Free Cash Flow per Share growth rate.


Diasorin SpA  (CHIX:DIAm) 3-Year FCF Growth Rate Explanation

Free Cash Flow per Share is the amount of Free Cash Flow per outstanding share of the company's stock. Free Cash Flow is considered one of the most important parameters to measure a company's earnings power by value investors because it is not subject to estimates of Depreciation, Depletion and Amortization (DDA). However, when we look at the Free Cash Flow, we should look from a long term perspective, because any year's Free Cash Flow can be drastically affected by the spending on Property, Plant, & Equipment (PPE) of the business in that year. Over the long term, Free Cash Flow should give pretty good picture on the real earnings power of the company. It's used in the calculation of Forward Rate of Return (Yacktman) %.


Diasorin SpA 3-Year FCF Growth Rate Related Terms

Thank you for viewing the detailed overview of Diasorin SpA's 3-Year FCF Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Diasorin SpA Business Description

Traded in Other Exchanges
Address
Via Crescentino Snc, Saluggia, Vercelli, ITA, 13040
DiaSorin, headquartered in Italy, is a global provider of in vitro diagnostics, or IVD, which refers to testing done on samples taken from the human body, such as blood and tissue. DiaSorin produces and markets testing reagent kits for immunodiagnostics (about 65% of total sales) and molecular diagnostics (about 20%) and has a total installed base of about 9,000 diagnostic systems. Instruments and other revenue contribute about 15% of total sales. DiaSorin's largest market in 2023 was North America, which accounted for 48% of non-covid revenue, followed by Europe (35%) and the Rest of the World (18%).

Diasorin SpA Headlines

No Headlines